Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
EPS for Cartesian Therapeutics (RNAC)
EPS in 2023 (TTM): -$0.32
According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.32. In 2021 the company made an earnings per share (EPS) of -$0.24 an increase over its 2020 EPS that were of -$0.69.
EPS history for Cartesian Therapeutics from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.32 | |
| 2021 | -$0.24 | -65.22% |
| 2020 | -$0.69 | -43.44% |
| 2019 | -$1.22 | -58.08% |
| 2018 | -$2.91 | -9.35% |
| 2017 | -$3.21 | -29.16% |
| 2016 | -$4.53 |